Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

Initial Study of Malaria Vaccine Pfs25-EPA/Alhydrogel(Registered Trademark)
Open Label Phase 1 Study in Malaria Naive Adults of the Safety and Immunogenicity of Pfs25-EPA/Alhydrogel, a Transmission Blocking Vaccine Against Plasmodium Falciparum
Status: Enrolling
Updated:  2/9/2012
Johns Hopkins University
mi
from
Baltimore, MD
Initial Study of Malaria Vaccine Pfs25-EPA/Alhydrogel(Registered Trademark)
Open Label Phase 1 Study in Malaria Naive Adults of the Safety and Immunogenicity of Pfs25-EPA/Alhydrogel, a Transmission Blocking Vaccine Against Plasmodium Falciparum
Status: Enrolling
Updated: 2/9/2012
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Acceptance of Human Papillomavirus Vaccination in Postpartum Women
Acceptance of Human Papillomavirus Vaccination in Postpartum Women
Status: Enrolling
Updated:  2/13/2012
Columbia University Medical Center
mi
from
New York, NY
Acceptance of Human Papillomavirus Vaccination in Postpartum Women
Acceptance of Human Papillomavirus Vaccination in Postpartum Women
Status: Enrolling
Updated: 2/13/2012
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Trial of a Falciparum Malaria Protein (FMP012), E. Coli-expressed PfCelTOS, in Healthy Malaria-Naive Adults
Phase 1 Study With the Vaccine Candidate Plasmodium Falciparum Malaria Protein (FMP012), an E.Coli-expressed Cell-Traversal Protein, Administered Intramuscularly in Healthy Malaria-Naive Adults
Status: Enrolling
Updated:  2/29/2012
Clinical Trials Center, WRAIR
mi
from
Silver Spring, MD
Trial of a Falciparum Malaria Protein (FMP012), E. Coli-expressed PfCelTOS, in Healthy Malaria-Naive Adults
Phase 1 Study With the Vaccine Candidate Plasmodium Falciparum Malaria Protein (FMP012), an E.Coli-expressed Cell-Traversal Protein, Administered Intramuscularly in Healthy Malaria-Naive Adults
Status: Enrolling
Updated: 2/29/2012
Clinical Trials Center, WRAIR
mi
from
Silver Spring, MD
Click here to add this to my saved trials
Web-Based Middle School HIV Prevention Curricula: Aspiring for Reach and Impact
Web-Based Middle School HIV Prevention Curricula: Aspiring for Reach and Impact
Status: Enrolling
Updated:  3/7/2012
University of Texas Houston School of Public Health
mi
from
Houston, TX
Web-Based Middle School HIV Prevention Curricula: Aspiring for Reach and Impact
Web-Based Middle School HIV Prevention Curricula: Aspiring for Reach and Impact
Status: Enrolling
Updated: 3/7/2012
University of Texas Houston School of Public Health
mi
from
Houston, TX
Click here to add this to my saved trials
Evaluation of the IND One Step Strep A Rapid Test vs. Culture
Evaluation of the IND One Step Strep A Rapid Test Versus Culture Using Clinical Throat Swab Samples From Patients With Suspected Strep A Infections, CLIA Waiver Study
Status: Enrolling
Updated:  3/7/2012
Pioneer Clinical Research, LLC
mi
from
Bellevue, NE
Evaluation of the IND One Step Strep A Rapid Test vs. Culture
Evaluation of the IND One Step Strep A Rapid Test Versus Culture Using Clinical Throat Swab Samples From Patients With Suspected Strep A Infections, CLIA Waiver Study
Status: Enrolling
Updated: 3/7/2012
Pioneer Clinical Research, LLC
mi
from
Bellevue, NE
Click here to add this to my saved trials
Evaluation of the IND One Step Strep A Rapid Test vs. Culture
Evaluation of the IND One Step Strep A Rapid Test Versus Culture Using Clinical Throat Swab Samples From Patients With Suspected Strep A Infections, CLIA Waiver Study
Status: Enrolling
Updated:  3/7/2012
HCCA Clinical Research
mi
from
Franklin, TN
Evaluation of the IND One Step Strep A Rapid Test vs. Culture
Evaluation of the IND One Step Strep A Rapid Test Versus Culture Using Clinical Throat Swab Samples From Patients With Suspected Strep A Infections, CLIA Waiver Study
Status: Enrolling
Updated: 3/7/2012
HCCA Clinical Research
mi
from
Franklin, TN
Click here to add this to my saved trials
Evaluation of the IND One Step Strep A Rapid Test vs. Culture
Evaluation of the IND One Step Strep A Rapid Test Versus Culture Using Clinical Throat Swab Samples From Patients With Suspected Strep A Infections, CLIA Waiver Study
Status: Enrolling
Updated:  3/7/2012
HCCA Clinical Research
mi
from
Smyrna, TN
Evaluation of the IND One Step Strep A Rapid Test vs. Culture
Evaluation of the IND One Step Strep A Rapid Test Versus Culture Using Clinical Throat Swab Samples From Patients With Suspected Strep A Infections, CLIA Waiver Study
Status: Enrolling
Updated: 3/7/2012
HCCA Clinical Research
mi
from
Smyrna, TN
Click here to add this to my saved trials
Revitalization of Teeth With Necrotic Pulps and Open Apexes Using Platelet-Rich Plasma
Revitalization of Teeth With Necrotic Pulps and Open Apexes Using Platelet-Rich Plasma
Status: Enrolling
Updated:  3/9/2012
Loma Linda University
mi
from
Loma Linda, CA
Revitalization of Teeth With Necrotic Pulps and Open Apexes Using Platelet-Rich Plasma
Revitalization of Teeth With Necrotic Pulps and Open Apexes Using Platelet-Rich Plasma
Status: Enrolling
Updated: 3/9/2012
Loma Linda University
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Revitalization of Teeth With Necrotic Pulps and Open Apexes Using Platelet-Rich Plasma
Revitalization of Teeth With Necrotic Pulps and Open Apexes Using Platelet-Rich Plasma
Status: Enrolling
Updated:  3/9/2012
Loma Linda Dental School
mi
from
Loma Linda, CA
Revitalization of Teeth With Necrotic Pulps and Open Apexes Using Platelet-Rich Plasma
Revitalization of Teeth With Necrotic Pulps and Open Apexes Using Platelet-Rich Plasma
Status: Enrolling
Updated: 3/9/2012
Loma Linda Dental School
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Postoperative Antibiotic Requirements Following Immediate Breast Reconstruction
Postoperative Antibiotic Requirements Following Immediate Breast Reconstruction
Status: Enrolling
Updated:  3/11/2012
Stony Brook University Medical Center
mi
from
Stony Brook, NY
Postoperative Antibiotic Requirements Following Immediate Breast Reconstruction
Postoperative Antibiotic Requirements Following Immediate Breast Reconstruction
Status: Enrolling
Updated: 3/11/2012
Stony Brook University Medical Center
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants
Phase 1/2 Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants
Status: Enrolling
Updated:  3/13/2012
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants
Phase 1/2 Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants
Status: Enrolling
Updated: 3/13/2012
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants
Phase 1/2 Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants
Status: Enrolling
Updated:  3/13/2012
Kosair Children's Hospital
mi
from
Louisville, KY
Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants
Phase 1/2 Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants
Status: Enrolling
Updated: 3/13/2012
Kosair Children's Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants
Phase 1/2 Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants
Status: Enrolling
Updated:  3/13/2012
University of Louisville Hospital
mi
from
Louisville, KY
Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants
Phase 1/2 Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants
Status: Enrolling
Updated: 3/13/2012
University of Louisville Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants
Phase 1/2 Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants
Status: Enrolling
Updated:  3/13/2012
University of Missouri Health Care, Columbia Regional Hospital
mi
from
Columbia, MO
Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants
Phase 1/2 Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants
Status: Enrolling
Updated: 3/13/2012
University of Missouri Health Care, Columbia Regional Hospital
mi
from
Columbia, MO
Click here to add this to my saved trials
Dietary Cholesterol and Defects in Cholesterol Synthesis in Mevalonate Kinase Deficiency
Dietary Cholesterol and Defects in Cholesterol Synthesis in Mevalonate Kinase Deficiency
Status: Enrolling
Updated:  3/21/2012
Oregon Health and Science University
mi
from
Portland, OR
Dietary Cholesterol and Defects in Cholesterol Synthesis in Mevalonate Kinase Deficiency
Dietary Cholesterol and Defects in Cholesterol Synthesis in Mevalonate Kinase Deficiency
Status: Enrolling
Updated: 3/21/2012
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Proof-of-Concept, Calcium Aluminosilicate Anti-Diarrheal for Treatment of Clostridium Difficile Infection
Proof-of-Concept, CASAD for Treatment of Clostridium Difficile Infection
Status: Enrolling
Updated:  4/3/2012
Scott & White Memorial Hospital
mi
from
Temple, TX
Proof-of-Concept, Calcium Aluminosilicate Anti-Diarrheal for Treatment of Clostridium Difficile Infection
Proof-of-Concept, CASAD for Treatment of Clostridium Difficile Infection
Status: Enrolling
Updated: 4/3/2012
Scott & White Memorial Hospital
mi
from
Temple, TX
Click here to add this to my saved trials
Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study of Intravenous (IV) TKM-100201 Infusion
A Placebo-Controlled, Single-Blind, Single-Ascending Dose Study With Additional Multiple-Ascending Dose Cohorts to Evaluate the Safety, Tolerability and Pharmacokinetics of TKM-100201 in Healthy Human Volunteers
Status: Enrolling
Updated:  4/9/2012
Cetero Research
mi
from
Fargo, ND
Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study of Intravenous (IV) TKM-100201 Infusion
A Placebo-Controlled, Single-Blind, Single-Ascending Dose Study With Additional Multiple-Ascending Dose Cohorts to Evaluate the Safety, Tolerability and Pharmacokinetics of TKM-100201 in Healthy Human Volunteers
Status: Enrolling
Updated: 4/9/2012
Cetero Research
mi
from
Fargo, ND
Click here to add this to my saved trials
Sauna Detoxification Study: Pilot Feasibility
Complementary and Alternative Medicine Detoxification: Safety and Efficacy
Status: Enrolling
Updated:  4/12/2012
Bastyr University Clinical Research Center
mi
from
Kenmore, WA
Sauna Detoxification Study: Pilot Feasibility
Complementary and Alternative Medicine Detoxification: Safety and Efficacy
Status: Enrolling
Updated: 4/12/2012
Bastyr University Clinical Research Center
mi
from
Kenmore, WA
Click here to add this to my saved trials
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation Or Infection With Adenovirus, CMV and EBV After Hemopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated:  4/16/2012
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation Or Infection With Adenovirus, CMV and EBV After Hemopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated: 4/16/2012
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation Or Infection With Adenovirus, CMV and EBV After Hemopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated:  4/16/2012
University of Californa Los Angeles (UCLA)
mi
from
Los Angeles, CA
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation Or Infection With Adenovirus, CMV and EBV After Hemopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated: 4/16/2012
University of Californa Los Angeles (UCLA)
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation Or Infection With Adenovirus, CMV and EBV After Hemopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated:  4/16/2012
University of Miami
mi
from
Miami, FL
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation Or Infection With Adenovirus, CMV and EBV After Hemopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated: 4/16/2012
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation Or Infection With Adenovirus, CMV and EBV After Hemopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated:  4/16/2012
Dana-Farber Cancer Institute
mi
from
Boston, MA
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation Or Infection With Adenovirus, CMV and EBV After Hemopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated: 4/16/2012
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation Or Infection With Adenovirus, CMV and EBV After Hemopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated:  4/16/2012
Hackensack University
mi
from
Hackensack, NJ
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation Or Infection With Adenovirus, CMV and EBV After Hemopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated: 4/16/2012
Hackensack University
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation Or Infection With Adenovirus, CMV and EBV After Hemopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated:  4/16/2012
Duke Univ Med Ctr
mi
from
Durham, NC
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation Or Infection With Adenovirus, CMV and EBV After Hemopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated: 4/16/2012
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation Or Infection With Adenovirus, CMV and EBV After Hemopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated:  4/16/2012
Texas Children's Hospital
mi
from
Houston, TX
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation Or Infection With Adenovirus, CMV and EBV After Hemopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated: 4/16/2012
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation Or Infection With Adenovirus, CMV and EBV After Hemopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated:  4/16/2012
Houston Methodist Hospital
mi
from
Houston, TX
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation Or Infection With Adenovirus, CMV and EBV After Hemopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated: 4/16/2012
Houston Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation Or Infection With Adenovirus, CMV and EBV After Hemopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated:  4/16/2012
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation Or Infection With Adenovirus, CMV and EBV After Hemopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated: 4/16/2012
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Interferon-alpha Treatment of Chronic Cough in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis
Evaluation of Natural Human Interferon Alpha Lozenges in the Treatment of Chronic Cough in Patients With Chronic Obstructive Pulmonary Disease (COPD) or Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  4/20/2012
Texas Tech University Health Sciences Center
mi
from
Lubbock, TX
Interferon-alpha Treatment of Chronic Cough in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis
Evaluation of Natural Human Interferon Alpha Lozenges in the Treatment of Chronic Cough in Patients With Chronic Obstructive Pulmonary Disease (COPD) or Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 4/20/2012
Texas Tech University Health Sciences Center
mi
from
Lubbock, TX
Click here to add this to my saved trials
Tacrolimus and ATG as GVHD Prophylaxis in Patients Undergoing Related Donor HSCT
A Phase II Study of Tacrolimus and Thymoglobulin, as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Related Donor Hematopoietic Cell Transplantation
Status: Enrolling
Updated:  4/30/2012
Barbara Ann Karmanos Cancer Institute
mi
from
Detroit, MI
Tacrolimus and ATG as GVHD Prophylaxis in Patients Undergoing Related Donor HSCT
A Phase II Study of Tacrolimus and Thymoglobulin, as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Related Donor Hematopoietic Cell Transplantation
Status: Enrolling
Updated: 4/30/2012
Barbara Ann Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Topical Treatment of Acute Otitis Media With Tympanostomy Tubes (AOMT) and Its Effect on Microbial Flora
Topical Treatment of Acute Otitis Media Through Tympanostomy Tubes (AOMT) and Its Effect on Microbial Flora Distal to the Site of Infection
Status: Enrolling
Updated:  5/3/2012
Alcon Call Center
mi
from
Fort Worth, TX
Topical Treatment of Acute Otitis Media With Tympanostomy Tubes (AOMT) and Its Effect on Microbial Flora
Topical Treatment of Acute Otitis Media Through Tympanostomy Tubes (AOMT) and Its Effect on Microbial Flora Distal to the Site of Infection
Status: Enrolling
Updated: 5/3/2012
Alcon Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
Central Arkansas Veterans Health System
mi
from
Little Rock, AR
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
Central Arkansas Veterans Health System
mi
from
Little Rock, AR
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
LA County/USC Medical Center
mi
from
Los Angeles, CA
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
LA County/USC Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
University of Southern California Medical Center
mi
from
Los Angeles, CA
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
University of Southern California Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
University of California at San Diego
mi
from
San Diego, CA
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
University of California at San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
University of California, San Francincisco
mi
from
San Francisco, CA
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
University of California, San Francincisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
Denver Department of Public Health and Hospitals
mi
from
Denver, CO
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
Denver Department of Public Health and Hospitals
mi
from
Denver, CO
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
Washington DC Veterans Administration Medical Center
mi
from
Washington DC,
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
Washington DC Veterans Administration Medical Center
mi
from
Washington DC,
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
Emory University School of Medicine
mi
from
Atlanta, GA
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
Emory University School of Medicine
mi
from
Atlanta, GA
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
Chicago VA Medical Center (Lakeside)
mi
from
Chicago, IL
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
Chicago VA Medical Center (Lakeside)
mi
from
Chicago, IL
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
Northwestern University
mi
from
Chicago, IL
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
Hines VA Medical Center
mi
from
Hines, IL
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
Hines VA Medical Center
mi
from
Hines, IL
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
Boston Med Center
mi
from
Boston, MA
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
Boston Med Center
mi
from
Boston, MA
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
New Jersey Medical School
mi
from
Newark, NJ
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
New Jersey Medical School
mi
from
Newark, NJ
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
Columbia University/Presbyterian Medical Center
mi
from
New York, NY
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
Columbia University/Presbyterian Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
Harlem Hospital, Columbia University
mi
from
New York, NY
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
Harlem Hospital, Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
Duke Univ Med Ctr
mi
from
Durham, NC
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
Nashville VA Medical Center
mi
from
Nashville, TN
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
Nashville VA Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
Veterans Administration Tennessee Valley Health Care System
mi
from
Nashville, TN
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
Veterans Administration Tennessee Valley Health Care System
mi
from
Nashville, TN
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
University of North Texas Health Science Center
mi
from
Fort Worth, TX
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
University of North Texas Health Science Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials